⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6959859 | 0.76 | — | — | |
| SCHEMBL95392 | 0.74 | — | — | |
| SCHEMBL17714618 | 0.70 | — | — | |
| SCHEMBL14091822 | 0.70 | — | — | |
| SCHEMBL17303094 | 0.70 | — | — | |
| SCHEMBL23707362 | 0.70 | — | — | |
| SCHEMBL6530708 | 0.70 | — | — | |
| SCHEMBL14432708 | 0.70 | — | — | |
| SCHEMBL8431988 | 0.70 | — | — | |
| SCHEMBL8431992 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105916499-A | 12-epi-pleuromutilins | 纳布里瓦治疗股份公司 | 2016-08-31 | — | — | CN | claimed |
| EP-0532809-B1 | Light-polarizing material based on ethylenediamine polyacetic acid derivatives | RESEARCH FRONTIERS INC (US) | 1996-02-28 | — | — | EP | claimed |
| EP-0532809-A1 | Light-polarizing material based on ethylenediamine polyacetic acid derivatives | RESEARCH FRONTIERS INCORPORATED (US) | 1993-03-24 | — | — | EP | claimed |
| EP-0413209-A1 | LHRH analogs | TAP Pharmaceuticals Inc. (US) | 1991-02-20 | — | — | EP | claimed |
| US-20230104311-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-04-06 | — | — | US | disclosed |
| EP-4106763-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2022-12-28 | — | — | EP | disclosed |
| CN-115515593-A | Novel 6-substituted 7-deazapurines and corresponding nucleosides as medicaments | 勒芬天主教大学 | 2022-12-23 | — | — | CN | disclosed |
| US-20220002279-A1 | NOVEL IMIDAZOLE DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20210317391-A1 | KIT FOR CLEANING AGENT AND METHOD FOR PREPARING CLEANING AGENT | FUJIFILM ELECTRONIC MATERIALS CO., LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| EP-3884940-A1 | NOVEL IMIDAZOLE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-20210276988-A1 | 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2021-09-09 | — | — | US | disclosed |
| CN-112996505-A | Novel imidazole derivatives | 大正制药株式会社 | 2021-06-18 | — | — | CN | disclosed |
| US-6809101-B2 | RNA POLYMERASES INHIBITORS; SUCH AS 5-(1-HYDROXY-1-(5-METHYL-OXAZOL-2-YL))METHYLENE-2-THIOXOTHIAZOLIDIN-4-ONE | SHIONOGI & CO., LTD. (JP) | 2004-10-26 | — | — | US | disclosed |
| US-20030203948-A1 | Compounds having anti-hepatitics c virus effect | Z-KAT, INC. | 2003-10-30 | — | — | US | disclosed |
| US-6521032-B1 | Inks yield magenta prints and dyeings having good fastness to light and high color brilliance | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-18 | — | — | US | disclosed |
| EP-1086999-B1 | Magenta-colouring inks containing copper complexes of azo dyes on the basis of 1-naphthol-di or trisulfonic acids | CIBA SC HOLDING AG (CH) | 2002-11-06 | — | — | EP | disclosed |
| EP-1086999-A2 | Magenta-colouring inks containing copper complexes of azo dyes on the basis of 1-naphthol-di or trisulfonic acids | Ciba SC Holding AG (CH) | 2001-03-28 | — | — | EP | disclosed |
| US-5300492-A | Suppressing levels of sex hormones in male or female mammals | TAP PHARMACEUTICALS (US) | 1994-04-05 | — | — | US | disclosed |
| US-5110904-A | Luteinizing hormone releasing hormone; suppression of sex hormones | ABBOTT LABORATORIES (US) | 1992-05-05 | — | — | US | disclosed |
| EP-0413209-A1 | LHRH analogs | TAP Pharmaceuticals Inc. (US) | 1991-02-20 | — | — | EP | disclosed |